NWAM LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
4,776
+34
| +0.7% | +$16K | 0.18% | 123 |
|
|
2025
Q1 | $2.3M | Sell |
4,742
-1,436
| -23% | -$696K | 0.2% | 114 |
|
|
2024
Q4 | $2.49M | Buy |
6,178
+1,178
| +24% | +$474K | 0.15% | 144 |
|
|
2024
Q3 | $2.33M | Buy |
5,000
+8
| +0.2% | +$3.72K | 0.14% | 151 |
|
|
2024
Q2 | $2.34M | Buy |
4,992
+132
| +3% | +$61.9K | 0.69% | 29 |
|
|
2024
Q1 | $1.99M | Sell |
4,860
-2
| -0% | -$821 | 0.16% | 127 |
|
|
2023
Q4 | $1.98M | Buy |
4,862
+11
| +0.2% | +$4.48K | 0.16% | 130 |
|
|
2023
Q3 | $1.69M | Sell |
4,851
-10
| -0.2% | -$3.48K | 0.17% | 121 |
|
|
2023
Q2 | $1.71M | Sell |
4,861
-12
| -0.2% | -$4.22K | 0.14% | 144 |
|
|
2023
Q1 | $1.54M | Sell |
4,873
-75
| -2% | -$23.6K | 0.16% | 137 |
|
|
2022
Q4 | $1.43M | Buy |
4,948
+30
| +0.6% | +$8.66K | 0.13% | 170 |
|
|
2022
Q3 | $1.42M | Buy |
4,918
+106
| +2% | +$30.7K | 0.14% | 154 |
|
|
2022
Q2 | $1.39M | Sell |
4,812
-961
| -17% | -$277K | 0.13% | 160 |
|
|
2022
Q1 | $1.51M | Sell |
5,773
-1
| -0% | -$261 | 0.12% | 178 |
|
|
2021
Q4 | $1.27M | Buy |
5,774
+3,339
| +137% | +$733K | 0.1% | 204 |
|
|
2021
Q3 | $442K | Buy |
+2,435
| New | +$442K | 0.04% | 346 |
|
|
2020
Q3 | – | Sell |
-1,169
| Closed | -$339K | – | 424 |
|
|
2020
Q2 | $339K | Buy |
1,169
+6
| +0.5% | +$1.74K | 0.05% | 307 |
|
|
2020
Q1 | $277 | Sell |
1,163
-100
| -8% | -$24 | 0.01% | 314 |
|
|
2019
Q4 | $277K | Buy |
+1,263
| New | +$277K | 0.05% | 313 |
|